Drug intelligence / Profile preview

Meilin

Development stage: Preclinical
Lead developer: Guizhou Yibai Pharmaceutical
Administration: Oral

Overview

Meilin Capsule is an orally administered drug currently undergoing clinical investigation for the treatment of symptoms related to ureteral stents following upper urinary calculi (damp-heat syndrome) operations. The development and study of this drug involve Guizhou Yibai Women's Pharmaceutical Co. LTD and Xiyuan Hospital of CACMS.

Other names: Meilin Capsulemilin capsule

Beyond the preview

Go deeper on Meilin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meilin.

Explore the full profile